✦ LIBER ✦

Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors

✍ Scribed by Toshihiko Doi, Atsushi Ohtsu, Nozomu Fuse…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

111 POSTER A dose escalation study of AM

✍ R. Herbst; R. Kurzrock; C. Storgard; E. Malseed; L. Rosen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 206 KB

708 POSTER AMG 386, a first-in-class, se

✍ A. Mita; D. Wang; C.H. Takimoto; D. Martin; L. Nguyen; E. Rasmussen; C. Storgard 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Phase 1 study of the investigational, or

✍ Yasuhito Fujisaka; Yasuhide Yamada; Noboru Yamamoto; Toshio Shimizu; Yutaka Fuji 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 364 KB

A phase 1 and dose-finding study of LY25

✍ Wakui, Hiroshi; Yamamoto, Noboru; Kitazono, Satoru; Mizugaki, Hidenori; Nakamich 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 366 KB

Phase 1 and dose-finding study of patrit

✍ Wakui, Hiroshi; Yamamoto, Noboru; Nakamichi, Shinji; Tamura, Yousuke; Nokihara, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 341 KB

Phase 1 study of conatumumab, a pro-apop

✍ T. Doi; H. Murakami; A. Ohtsu; N. Fuse; T. Yoshino; N. Yamamoto; N. Boku; Y. Ono 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 237 KB